VCNDD drug candidate enters clinical trials at Vanderbilt.

Written By Alex tapper

WSMV Channel 4 - Nashville

Alex tapper

Just here to help out.

Previous

Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study
Next

Vanderbilt begins phase 1 trials of new Alzheimer’s drug